|
Information For:
|
Revision BulletinFexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the tolerances and chromatographic method in Dissolution Test 3 in the Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets monograph. Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated into the First Supplement to the USP 33-NF 28 Reissue. Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or ). Download the Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets Revision Bulletin What's New![]() Second Customer Notice (03/10/10)
Third Public Notice (03/05/10)
USP is Recalling USP 33–NF 28 Due to Errors. (01/26/10)
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||